Hypoxia promotes chemotherapy resistance by down-regulating SKA1 gene expression in human osteosarcoma

References

• Rejniak KA, Lloyd MC, Reed DR, Bui MM. Diagnostic assessment of osteosarcoma chemoresistance based on virtual clinical trials. Med Hypotheses 2015; 85:348-54; PMID:26130106; http://dx.doi.org/10.1016/j.mehy.2015.06.015
   PubMed Web of Science ®Google Scholar
• Joseph CG, Hwang H, Jiao Y, Wood LD, Kinde I, Wu J, Mandahl N, Luo J, Hruban RH, Diaz LJ, et al. Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas. Genes Chromosomes Cancer 2014; 53:15-24; PMID:24190505; http://dx.doi.org/10.1002/gcc.22114
   PubMed Web of Science ®Google Scholar
• Jeon DG, Cho WH, Song WS, Kong CB, Cho SH, Lee JW, Lee SY. Correlation between fluid-fluid levels on initial mri and the response to chemotherapy in stage iib osteosarcoma. Ann Surg Oncol 2014; 21:1956-62; PMID:24577812; http://dx.doi.org/10.1245/s10434-014-3603-z
   PubMed Web of Science ®Google Scholar
• Habel N, Hamidouche Z, Girault I, Patino-Garcia A, Lecanda F, Marie PJ, Fromigue O. Zinc chelation: a metallothionein 2a's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance. Cell Death Dis 2013; 4:e874; PMID:24157868; http://dx.doi.org/10.1038/cddis.2013.405
   PubMed Web of Science ®Google Scholar
• Xu Y, Qiu L. Nonspecifically enhanced therapeutic effects of vincristine on multidrug-resistant cancers when coencapsulated with quinine in liposomes. Int J Nanomedicine 2015; 10:4225-37; PMID:26170660; http://dx.doi.org/10.2147/IJN.S84555
   PubMed Web of Science ®Google Scholar
• Roncuzzi L, Pancotti F, Baldini N. Involvement of hif-1alpha activation in the doxorubicin resistance of human osteosarcoma cells. Oncol Rep 2014; 32:389-94; PMID:24840054; http://dx.doi.org//10.3892/or.2014.3181
   PubMed Web of Science ®Google Scholar
• Chen J, Ding Z, Peng Y, Pan F, Li J, Zou L, Zhang Y, Liang H. Hif-1alpha inhibition reverses multidrug resistance in colon cancer cells via downregulation of mdr1/p-glycoprotein. Plus One 2014; 9:e98882; PMID:26063960; http://dx.doi.org/10.1371/journal.pone.0098882
   PubMed Web of Science ®Google Scholar
• Lin SC, Liao WL, Lee JC, Tsai SJ. Hypoxia-regulated gene network in drug resistance and cancer progression. Exp Biol Med (Maywood) 2014; 239:779-92; PMID:24812122; http://dx.doi.org/10.1177/1535370214532755
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. The tumour suppressor protein vhl targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-5; PMID: 10353251; http://dx.doi.org/10.1038/20459
   PubMed Web of Science ®Google Scholar
• Chen X, Yang TT, Wang W, Sun HH, Ma BA, Li CX, Ma Q, Yu Z, Fan QY. Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials. Cytotechnology 2009; 61:37-44; PMID: 20016965; http://dx.doi.org/10.1007/s10616-009-9239-3
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method. Methods 2001; 25:402-8; PMID: 11846609; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Rocha GZ, Dias MM, Ropelle ER, Osorio-Costa F, Rossato FA, Vercesi AE, Saad MJ, Carvalheira JB. Metformin amplifies chemotherapy-induced ampk activation and antitumoral growth. Clin Cancer Res 2011; 17:3993-4005; PMID: 21543517; http://dx.doi.org/10.1158/1078-0432.CCR-10-2243
   PubMed Web of Science ®Google Scholar
• Schmidt JC, Arthanari H, Boeszoermenyi A, Dashkevich NM, Wilson-Kubalek EM, Monnier N, Markus M, Oberer M, Milligan RA, Bathe M, et al. The kinetochore-bound ska1 complex tracks depolymerizing microtubules and binds to curved protofilaments. Dev Cell 2012; 23:968-80; PMID: 23085020; http://dx.doi.org/10.1016/j.devcel.2012.09.012
   PubMed Web of Science ®Google Scholar
• Guimaraes GJ, Deluca JG. Connecting with ska, a key complex at the kinetochore-microtubule interface. EMBO J 2009; 28:1375-7; PMID: 19458608; http://dx.doi.org/10.1038/emboj.2009.124
   PubMed Web of Science ®Google Scholar
• Hanisch A, Sillje HH, Nigg EA. Timely anaphase onset requires a novel spindle and kinetochore complex comprising ska1 and ska2. EMBO J 2006; 25:5504-15; PMID: 17093495; http://dx.doi.org/10.1038/sj.emboj.7601426
   PubMed Web of Science ®Google Scholar
• Jeyaprakash AA, Santamaria A, Jayachandran U, Chan YW, Benda C, Nigg EA, Conti E. Structural and functional organization of the ska complex, a key component of the kinetochore-microtubule interface. Mol Cell 2012; 46:274-86; PMID: 22483620; http://dx.doi.org/10.1016/j.molcel.2012.03.005
   PubMed Web of Science ®Google Scholar
• Li J, Xuan JW, Khatamianfar V, Valiyeva F, Moussa M, Sadek A, Yang BB, Dong BJ, Huang YR, Gao WQ. Ska1 over-expression promotes centriole over-duplication, centrosome amplification and prostate tumourigenesis. J Pathol 2014; 234:178-89; PMID: 24827423; http://dx.doi.org/10.1002/path.4407
   PubMed Web of Science ®Google Scholar
• Dong C, Wang XL, Ma BL. Expression of spindle and kinetochore-associated protein 1 is associated with poor prognosis in papillary thyroid carcinoma. Dis Markers 2015; 2015:616541; PMID:26063960; http://dx.doi.org/10.1155/2015/616541
   PubMed Web of Science ®Google Scholar
• Sun W, Yao L, Jiang B, Guo L, Wang Q. Spindle and kinetochore-associated protein 1 is overexpressed in gastric cancer and modulates cell growth. Mol Cell Biochem 2014; 391:167-74; PMID: 24627241; http://dx.doi.org/10.1007/s11010-014-1999-1
   PubMed Web of Science ®Google Scholar
• Qin X, Yuan B, Xu X, Huang H, Liu Y. Effects of short interfering rna-mediated gene silencing of ska1 on proliferation of hepatocellular carcinoma cells. Scand J Gastroenterol 2013; 48:1324-32; PMID: 24010405; http://dx.doi.org/10.3109/00365521.2013.828774
   PubMed Web of Science ®Google Scholar
• Roncuzzi L, Pancotti F, Baldini N. Involvement of hif-1alpha activation in the doxorubicin resistance of human osteosarcoma cells. Oncol Rep 2014; 32:389-94; PMID:24840054; http://dx.doi.org/10.3892/or.2014.3181
   PubMed Web of Science ®Google Scholar
• Li S, Sun W, Wang H, Zuo D, Hua Y, Cai Z. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal. Tumour Biol 2015; 36:1329-38; PMID:25666750; http://dx.doi.org/10.1007/s13277-015-3181-0
   PubMed Web of Science ®Google Scholar
• Lv Y, Zhao S, Han J, Zheng L, Yang Z, Zhao L. Hypoxia-inducible factor-1alpha induces multidrug resistance protein in colon cancer. Onco Targets Ther 2015; 8:1941-8; PMID:26251616; http://dx.doi.org/10.2147/OTT.S82835
   PubMed Web of Science ®Google Scholar